Related references
Note: Only part of the references are listed.A Pituitary Society update to acromegaly management guidelines
Maria Fleseriu et al.
PITUITARY (2021)
Complications and Comorbidities of Acromegaly-Retrospective Study in Polish Center
Malgorzata Rolla et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Vertebral Fractures Occur Despite Control of Acromegaly and Are Predicted by Cortical Volumetric Bone Mineral Density
Martin Kuzma et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
The place of medical treatment of acromegaly in Serbia: current status
Mirjana Doknic et al.
VOJNOSANITETSKI PREGLED (2021)
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
Andrea Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
COMPARATIVE EFFICACY OF MEDICAL TREATMENT FOR ACROMEGALY: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF INTEGRATED RANDOMIZED TRIALS AND OBSERVATIONAL STUDIES
Nidan Qiao et al.
ENDOCRINE PRACTICE (2020)
Fractionated radiotherapy and radiosurgery in acromegaly: analysis of 352 patients from the German Acromegaly Registry
U. J. Knappe et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Improvement of acromegaly control with multimodal therapy in Romania
Mihai C. Marinescu et al.
ENDOKRYNOLOGIA POLSKA (2020)
Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs
Monica Gadelha et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
MEDICAL TREATMENT LANDSCAPE FOR ACTIVE ACROMEGALY IN A PITUITARY CENTER IN ISRAEL
Hiba Masri-Iraqi et al.
ENDOCRINE PRACTICE (2020)
Therapeutic effect of presurgical treatment with longacting octreotide (Sandostatin® LAR®) in patients with acromegaly
Marek Bolanowski (Wrocław) et al.
Endokrynologia Polska (2020)
Stereotactic Radiosurgery for Acromegaly: An International Multicenter Retrospective Cohort Study
Dale Ding et al.
NEUROSURGERY (2019)
National acromegaly registries
Luigi Maione et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
The real costs of acromegaly: analysis of different therapies
Michal Elbaum et al.
ENDOKRYNOLOGIA POLSKA (2019)
Diagnostics and treatment of acromegaly - updated recommendations of the Polish Society of Endocrinology
Marek Bolanowski et al.
ENDOKRYNOLOGIA POLSKA (2019)
Pegvisomant Improves Glucose Metabolism in Acromegaly: A Meta-Analysis of Prospective Interventional Studies
Tiziana Feola et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Acromegaly
Annamaria Colao et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT® validation study
Andrea Giustina et al.
PITUITARY (2019)
Development of a novel patient-reported measure for acromegaly: the Acro-TSQ
Maria Fleseriu et al.
PITUITARY (2019)
Association of Vitamin D Receptor Polymorphisms With Activity of Acromegaly, Vitamin D Status and Risk of Osteoporotic Fractures in Acromegaly Patients
Aleksandra Jawiarczyk-Przybylowska et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Non-invasive DXA-derived bone structure assessment of acromegaly patients: a cross-sectional study
Martin Kuzma et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
How to Position Pasireotide LAR Treatment in Acromegaly
Eva C. Coopmans et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Signs and symptoms of acromegaly at diagnosis: the physician's and the patient's perspectives in the ACRO-POLIS study
Philippe Caron et al.
ENDOCRINE (2019)
Effectiveness and safety of pegvisomant: a systematic review and meta-analysis of observational longitudinal studies
Leticia P. Leonart et al.
ENDOCRINE (2019)
Hepatic steatosis in patients with acromegaly
Andreani Koutsou-Tassopoulou et al.
ENDOCRINOLOGY DIABETES & METABOLISM (2019)
Increasing frequency of combination medical therapy in the treatment of acromegaly with the GH receptor antagonist pegvisomant
Christian J. Strasburger et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
A Consensus Statement on acromegaly therapeutic outcomes
Shlomo Melmed et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Cost-effectiveness of acromegaly treatments: a systematic review
Leticia P. Leonart et al.
PITUITARY (2018)
Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY
Michael Buchfelder et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Hepatic Steatosis Index in Acromegaly: Correlation with Insulin Resistance Regardless of the Disease Control
Alessandro Ciresi et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2018)
Efficacy and safety of long-acting pasireotide in patients with somatostatin-resistant acromegaly: a multicenter study
Ilan Shimon et al.
ENDOCRINE (2018)
Prevalence and risk factors of sleep breathing disorders in patients with acromegaly from Moscow region
Yu A. Kovaleva et al.
TERAPEVTICHESKII ARKHIV (2018)
Acromegaly treatment in Romania. How close are we to disease control?
Dan Alexandru Niculescu et al.
ENDOKRYNOLOGIA POLSKA (2017)
Acromegaly at diagnosis in 3173 patients from the Liege Acromegaly Survey (LAS) Database
Patrick Petrossians et al.
ENDOCRINE-RELATED CANCER (2017)
Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry
Luigi Maione et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Classification of Patients With GH Disorders May Vary According to the IGF-I Assay
Maria Mavromati et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
High-Dose and High-Frequency Lanreotide Autogel in Acromegaly: A Randomized, Multicenter Study
Andrea Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly
Aart J. van der Lely et al.
PITUITARY (2017)
Biochemical investigations in diagnosis and follow up of acromegaly
Katharina Schilbach et al.
PITUITARY (2017)
Pegvisomant in acromegaly: an update
A. Giustina et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2017)
ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease
Nunzia Prencipe et al.
CLINICAL ENDOCRINOLOGY (2016)
SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice-development and results from a pilot study
Andrea Giustina et al.
PITUITARY (2016)
Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy)
Annamaria Colao et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Acromegaly: An Endocrine Society Clinical Practice Guideline
Laurence Katznelson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
A. Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Vertebral Fractures in Patients With Acromegaly: A 3-Year Prospective Study
G. Mazziotti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Bone properties in patients with acromegaly: Quantitative ultrasound of the heel
Darko Kastelan et al.
JOURNAL OF CLINICAL DENSITOMETRY (2007)
Gamma knife radiosurgery for acromegaly -: long-term experience
J Jezková et al.
CLINICAL ENDOCRINOLOGY (2006)
Share Paper
